Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

UniQure

since

auto-detected in 2 stories

5 months ago

UniQure's experimental gene therapy for Huntington's disease slowed progression of the brain disorder by 75% in an early-to-mid stage study, the company said.
These are the stocks posting the largest moves in midday trading.

page 1 of 1